You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Product overview

Augmentin (amoxicillin-clavulanate) is indicated for short-term treatment of bacterial infections caused by susceptible organisms.

Find out more

Adverse events should be reported directly to the HPRA; Freepost, Pharmacovigilance Section, Health Products Regulatory Authority, Earlsfort Terrace, Dublin 2, Tel: +353 1 676 4971 medsafety@hpra.ie . Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Augmentin is a registered trademark of the GlaxoSmithKline group of companies